Hyperprolactinemia may be induced through dopamine antagonism (antipsychotics) or serotonin stimulation (clomipramine), while LHRH agonists have been documented to compensate the hyperprolactinemia present in microprolactinomas [64,65]. Here, GNRH1 is linked to Microprolactinoma.